OTCMKTS:CDMGF Icade (CDMGF) Stock Price, News & Analysis → AI healthcare stock poised for 36,996% growth? (From Behind the Markets) (Ad) Free CDMGF Stock Alerts $27.00 0.00 (0.00%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$27.00▼$27.0050-Day Range$27.00▼$37.0052-Week Range$27.00▼$47.14VolumeN/AAverage Volume800 shsMarket CapitalizationN/AP/E Ratio22.10Dividend Yield13.59%Price TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartShort InterestStock AnalysisAnalyst ForecastsChartShort Interest Get Icade alerts: Email Address Ad Behind the MarketsAI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...Get the name of the stock here... About Icade Stock (OTCMKTS:CDMGF)Icade is a full-service real estate company with expertise in both commercial property investment (portfolio worth 6.8bn on a full consolidation basis as of 12/31/2023) and property development (2023 economic revenue of 1.3bn) that operates throughout France. Icade has forged longterm partnerships to respond to emerging trends in the industry. It has made climate issues and the preservation of biodiversity central to its business model to reinvent real estate and contribute to more sustainable cities. It is listed as a SIIC on Euronext Paris and its leading shareholder is the Caisse des Dépôts group.Read More CDMGF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDMGF Stock News HeadlinesFebruary 28, 2024 | seekingalpha.comIcade: Poised To OutperformAugust 13, 2023 | msn.comIcade REIT: More Attractive Than Before With A 12% YieldMarch 28, 2024 | Behind the Markets (Ad)AI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...August 11, 2023 | msn.comIcade: More Attractive Than Before With A Massive YieldNovember 28, 2022 | marketwatch.comIcad Rises on Google Health Development DealNovember 10, 2022 | msn.comIcad (ICAD) Reports Q3 Loss, Lags Revenue EstimatesSeptember 23, 2022 | finance.yahoo.comIcade (ICAD.PA)August 19, 2022 | nasdaq.comAfter Plunging 29.6% in 4 Weeks, Here's Why the Trend Might Reverse for Icad (ICAD)March 28, 2024 | Behind the Markets (Ad)AI healthcare stock poised for 36,996% growth?Buy Alert Issued For AI Small Cap Our last two AI stocks jumped 150% and 130%... But we just issued a brand new "buy alert" for a new one...May 15, 2022 | seekingalpha.comIcade: Align Yourself With French Governmental Real EstateFebruary 28, 2022 | sfgate.comIcad: Q4 Earnings SnapshotFebruary 21, 2022 | msn.comAnalysts Estimate Icad (ICAD) to Report a Decline in Earnings: What to Look Out forNovember 9, 2021 | entrepreneur.comIcad (ICAD) Reports Q3 Loss, Misses Revenue EstimatesNovember 9, 2021 | chron.comIcad: Q3 Earnings SnapshotNovember 2, 2021 | msn.comEarnings Preview: Icad (ICAD) Q3 Earnings Expected to DeclineSeptember 16, 2021 | benzinga.comDirector Of Icad Makes $217.70 Thousand SaleAugust 5, 2021 | nasdaq.comIcad (ICAD) Reports Q2 Loss, Lags Revenue EstimatesJuly 29, 2021 | finance.yahoo.comIcad (ICAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseSee More Headlines Receive CDMGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Icade and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorReal Estate Industry REIT - Diversified Sub-IndustryN/A Current SymbolOTCMKTS:CDMGF CUSIPN/A CIKN/A Webwww.icade.fr Phone33 1 41 57 70 00FaxN/AEmployees1,124Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio22.10 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Nicolas JolyChief Executive OfficerMs. Victoire Aubry (Age 58)Head of Finance, IT & Work Environment Ms. Sophie DuvalHead of Consolidation & AccountingMs. Anne-Violette FaugerasDirector of Financing & Investor RelationsMr. Jérôme Lucchini (Age 57)General Secretary and Head of Governance, Legal Insurance & Department Ms. Emmanuelle Baboulin (Age 58)Head of the Commercial Property Investment Division Mr. Xavier de La SudrieHead of Financial ControlJohannah MrejenHead of Asset ManagementMr. Guillaume TesslerHead of International Development - Icade SantéMr. Henri ChapouthierHead of Sustainable DevelopmentMore ExecutivesKey CompetitorsArtis Real Estate Investment TrustOTCMKTS:ARESFCapitaLand Ascott TrustOTC:ATTRFCenturia Capital GroupOTCMKTS:CNECFCharter Hall Long WALE REITOTCMKTS:CHLWFCofinimmoOTCMKTS:CFMOFView All Competitors CDMGF Stock Analysis - Frequently Asked Questions Should I buy or sell Icade stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Icade in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CDMGF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CDMGF, but not buy additional shares or sell existing shares. View CDMGF analyst ratings or view top-rated stocks. How have CDMGF shares performed in 2024? Icade's stock was trading at $37.00 at the start of the year. Since then, CDMGF stock has decreased by 27.0% and is now trading at $27.00. View the best growth stocks for 2024 here. Are investors shorting Icade? Icade saw a increase in short interest in February. As of February 15th, there was short interest totaling 269,700 shares, an increase of 5.5% from the January 31st total of 255,700 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,697.0 days. View Icade's Short Interest. Is Icade a good dividend stock? Icade (OTCMKTS:CDMGF) pays an annual dividend of $3.67 per share and currently has a dividend yield of 6.28%. CDMGF has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 300.37%. Payout ratios above 75% are not desirable because they may not be sustainable. How do I buy shares of Icade? Shares of CDMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:CDMGF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icade Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.